KEY POINTS
- The R&D Tax Concession was introduced in 1985 to encourage Australian industry to undertake more research and development (R&D) activities.
- From the 2010-11 income year it will be replaced with a new R&D Tax Credit in accordance with the Government’s 2009-10 Budget measures.
- The current R&D Tax Concession comprises of:
- a tax deduction of up to 125% for R&D expenditure
- a 175% Premium tax deduction for increases in R&D expenditure above a rolling three year average
- a 175% International Premium for eligible R&D undertaken in Australia, regardless of where the intellectual property is held
- an R&D Tax Offset for companies spending less than $1m for the year and with a turnover of less than $5m.
- as an interim measure prior to the commencement of the R&D Tax Credit, the R&D expenditure cap for the R&D Tax Offset has been lifted from $1 million to $2 million for 2009-10, providing a tangible demonstration of increased Government support for R&D by small companies.
- For the 2007-08 financial year, 7,754 companies were registered for the tax concession; this is a 14% increase on the previous year. These companies reported R&D expenditure of $14.2 billion, an increase of 22% on the previous year. Based on 30 June 2009 data:
- 39% of registered companies used the 125% to claim a tax deduction
- 19% used the 175% Premium to claim a tax deduction
- 35% used the Tax Offset at the 125% and 7% at the 175% rate.
FACTS AND FIGURES
The objective of the R&D Tax Concession is to provide a tax incentive in the form of a deduction, to make eligible companies more internationally competitive by:
- encouraging the development by eligible companies of innovative products, processes and services
- increasing investment by eligible companies in defined R&D activities
- promoting the technological advancement of eligible companies through a focus on innovation or high technical risk in defined R&D activities
- encouraging the use by eligible companies of strategic R&D planning
- creating an environment that is conducive to increased commercialisation of new processes and product technologies developed by eligible companies.
R&D Tax Concession data 1985-86 to 2007-08 (as at 30 June 2009)
|
Financial Year |
Company Tax Rate (%) |
R&D Tax Concession Rate (%) |
Indicative Benefit after tax (%) |
Number of Companies Registered |
Total R&D Expenditure ($m) |
|
1985-86 |
46 |
150 |
23 |
2,549 |
108 |
|
1986-87 |
49 |
150 |
24.5 |
1,666 |
731 |
|
1987-88 |
49 |
150 |
24.5 |
2,067 |
1,093 |
|
1988-89 |
39 |
150 |
19.5 |
2,153 |
1,322 |
|
1989-90 |
39 |
150 |
19.5 |
2,365 |
1,625 |
|
1990-91 |
39 |
150 |
19.5 |
2,499 |
2,190 |
|
1991-92 |
39 |
150 |
19.5 |
2,836 |
2,698 |
|
1992-93 |
39 |
150 |
19.5 |
2,960 |
2,973 |
|
1993-94 |
33 |
150 |
16.5 |
3,436 |
3,392 |
|
1994-95 |
33 |
150 |
16.5 |
3,624 |
3,958 |
|
1995-96 |
36 |
150 |
18 |
3,734 |
4,470 |
|
1996-97 |
36 |
125 |
9 |
3,295 |
4,174 |
|
1997-98 |
36 |
125 |
9 |
3,304 |
4,354 |
|
1998-99 |
36 |
125 |
9 |
3,185 |
5,095 |
|
1999-00 |
36 |
125 |
9 |
3,274 |
4,920 |
|
2000-01 |
34 |
125 |
8.5 |
3,734 |
5,670 |
|
2001-02 |
30 |
125 175 |
7.5 22.5 |
4,755 |
6,092 |
|
2002-03 |
30 |
125 175 |
7.5 22.5 |
5,095 |
6,363 |
|
2003-04 |
30 |
125 175 |
7.5 22.5 |
5,639 |
6,922 |
|
2004-05 |
30 |
125 175 |
7.5 22.5 |
5,985 |
8,263 |
|
2005-06 |
30 |
125 175 |
7.5 22.5 |
6,408 |
9,734 |
|
2006-07 |
30 |
125 175 |
7.5 22.5 |
6,806 |
11,595 |
| 2007-08 |
30 |
125 175 |
7.5 22.5 |
7,754 |
14,191 |